Benzinga's Top Initiations

Analysts at Barclays initiated coverage on ISIS Pharmaceuticals, Inc. ISIS with a Equal-weight rating. The target price for ISIS Pharmaceuticals is set to $60. ISIS Pharmaceuticals shares closed at $50.20 on Monday. RBC Capital initiated coverage on Centurylink Inc CTL with a Sector Perform rating. The target price for Centurylink is set to $28. Centurylink shares closed at $25.88 on Monday. Analysts at Keefe Bruyette & Woods initiated coverage on Middlefield Banc Corp MBCN with a Market Perform rating. The target price for Middlefield Banc is set to $35. Middlefield Banc shares closed at $30.62 on Monday. Analysts at Barclays initiated coverage of Halozyme Therapeutics, Inc. HALO with a Overweight rating. The target price for Halozyme Therapeutics is set to $27. Halozyme Therapeutics shares closed at $18.22 on Monday. Analysts at RBC Capital initiated coverage on Level 3 Communications, Inc. LVLT with a Outperform rating. The target price for Level 3 Communications is set to $62. Level 3 Communications shares closed at $46.32 on Monday. Analysts at Danske Bank initiated coverage of Golar LNG Partners LP GMLP with a Buy rating. The target price for Golar LNG Partners is set to $24. Golar LNG Partners shares closed at $18.39 on Monday. Craig-Hallum initiated coverage of Zendesk Inc ZEN with a Buy rating. Zendesk shares closed at $21.75 on Monday. Analysts at H.C. Wainwright initiated initiated coverage on Conatus Pharmaceuticals Inc CNAT with a Buy rating. The target price for Conatus Pharmaceuticals is set to $15. Conatus Pharmaceuticals shares closed at $4.34 on Monday. Stifel Nicolau initiated coverage on Infoblox Inc BLOX with a Buy rating. The target price for Infoblox is set to $23. Infoblox shares closed at $17.77 on Monday. Analysts at Benchmark initiated coverage on Spectranetics Corp SPNC with a Buy rating. The target price for Spectranetics is set to $24. Spectranetics shares closed at $14.80 on Monday.